ABT vs CMP · P/E 25, rev $44.33B vs rev $1.12B
Abbott Laboratories (ABT) versus Compass Minerals International Inc (CMP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Compass Minerals International Inc (CMP) is a other industrial metals & mining company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CMP revenue for 2024-09-30 was $1.12B. Net income was -$206.1M. Revenue was down 7.2% from 2023-09-30 to 2024-09-30. CMP currently screens at market cap $916.5M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CMP currently screens at market cap $916.5M.
Not investment advice. Open the ABT and CMP stock pages for the full models.
Not investment advice.